GERBER HANS-PETER (CHIEF SCIENTIFIC OFFICER) exercised options at SUTRO BIOPHARMA, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/4/2025ACC: 0001415889-25-006696
Officer· CHIEF SCIENTIFIC OFFICER
Since Mar 2026
-4.62K
Net shares
Net seller
$7.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
11.25K acquired · 15.87K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.25K
Price / share
—
Trade value
—
% of position
46.6%
3/1/2025
24.12K→35.37K
Common Stock
Direct
Shares
−4.62K
Price / share
$1.59
Trade value
$7.35K
% of position
13.1%
3/1/2025
35.37K→30.75K
Total
Net shares
+6.63K
Net value
-$7.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | M · Option Exercise | +11.25K | — | — | 46.6% | 24.12K | 35.37K |
| Common Stock Direct | 3/1/2025 | F · Tax Withholding | −4.62K | $1.59 | $7.35K | 13.1% | 35.37K | 30.75K |
| Total | +6.63K | -$7.35K | ||||||
Derivative Transactions1
Restricted Stock Units (RSUs)
Direct
Converts to
Common Stock
11.25K shares
Shares
−11.25K
Strike price
Held after
33.75K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs) Direct | Common Stock11.25K shares | 3/1/2025 | M · Option Exercise | −11.25K | — | 33.75K |